keyword
MENU ▼
Read by QxMD icon Read
search

Encapsulating peritoneal sclerosis

keyword
https://www.readbyqxmd.com/read/27781116/case-report-of-a-patient-undergoing-peritoneal-dialysis-with-encapsulating-peritoneal-sclerosis-superimposed-with-calciphylaxis
#1
Jun Li Tsai, Ming Ju Wu, Cheng Hsu Chen, Shang Feng Tsai
INTRODUCTION: Encapsulating peritoneal sclerosis (EPS) is a rare but devastating complication of peritoneal dialysis (PD). Tamoxifen has been generally well-tolerated, even without randomized controlled trials. CASE PRESENTATION: Herein, we report a case of a patient undergoing 12 years of PD who developed EPS and calciphylaxis simultaneously. We also provide a comprehensive discussion about the association between EPS and calciphylaxis. Moreover, although tamoxifen is used in EPS due to its inhibition of fibroblast-transforming growth factor beta (TGFβ) production, it may worsen the calciphylaxis due to a hypercoagulable state...
August 2016: Iranian Red Crescent Medical Journal
https://www.readbyqxmd.com/read/27774831/risk-factors-of-severe-peritoneal-sclerosis-in-chronic-peritoneal-dialysis-patients
#2
Sudabeh Alatab, Iraj Najafi, Gholamreza Pourmand, Mostafa Hosseini, Soroosh Shekarchian
Peritoneal dialysis (PD) offers the healthiest way for starting renal replacement therapy (RRT) in End Stage Renal Disease patients, however exposes long-term PD patients to a dangerous complication named encapsulating peritoneal sclerosis (EPS). In this study, we searched for possible risk factors of EPS. Data were collected from two PD centers covering period 1995-2012 and comprised 464 patients. Control group defined as PD patients stayed on PD >42 month (n = 122), and case group was 12 confirmed EPS patients...
October 24, 2016: Renal Failure
https://www.readbyqxmd.com/read/27723234/a-combination-of-corticosteroid-sirolimus-and-intradialytic-parenteral-nutrition-in-encapsulating-peritoneal-sclerosis-case-report-and-literature-review
#3
Alexandre Minetto Brabo, Nayrana Soares Do Carmo Reis, Pasqual Barretti, Daniela Ponce
Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis that carries a high morbidity and mortality. Although its pathogenesis is still not clear, the "two hit theory" suggests that long term deterioration of the peritoneum combined with intraperitoneal inflammation is needed in the pathogenesis of EPS. To date, there is no proven effective therapy with an absence of randomized controlled trials. Individual case reports and small case series have reported on the use of tamoxifen and corticosteroids for medical management of EPS...
October 9, 2016: Hemodialysis International
https://www.readbyqxmd.com/read/27721224/a-new-experience-with-encapsulating-peritoneal-sclerosis-role-of-early-intervention
#4
Tahere Sadat Kalantarian, Iraj Najafi
After 20 years of peritoneal dialysis in Iran, we have encountered with several cases of encapsulating peritoneal sclerosis (EPS) in past few years. Many of these cases remained undiagnosed until advanced stages due to lack of suspicion. In centers with more experience about EPS, mortality has decreased by early diagnostic interventions. Peritoneal dialysis nurses may not be aware of EPS and radiologists are usually not familiar with EPS, either. To increase knowledge about this condition, we decided to present this review article with the case study of one of the 1st patients with EPS at our center...
September 2016: Iranian Journal of Kidney Diseases
https://www.readbyqxmd.com/read/27659928/percutaneous-endoscopic-gastrostomy-with-jejunal-extension-for-an-encapsulating-peritoneal-sclerosis-refractory-to-surgical-enterolysis
#5
Masataka Banshodani, Hideki Kawanishi, Misaki Moriishi, Sadanori Shintaku, Shinji Hashimoto, Shinichiro Tsuchiya
Surgical enterolysis is the final option for patients with encapsulating peritoneal sclerosis (EPS). However, EPS is sometimes refractory to surgical enterolysis. This is the first report of successful use of percutaneous endoscopic gastrostomy with jejunal extension (PEG-J) in a patient with EPS that was refractory to surgical enterolysis. We propose that sustained drainage of digestive juices by PEG-J, along with central venous nourishment at home, can be a treatment option for patients with EPS that cannot be treated with radical measures...
September 2016: Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
https://www.readbyqxmd.com/read/27628605/a-case-of-encapsulating-peritoneal-sclerosis-complicated-by-malignant-peritoneal-mesothelioma
#6
Genta Kanai, Takatoshi Kakuta, Takashi Hirukawa, Chizuko Okamatsu, Masafumi Fukagawa
We report a case of peritoneal mesothelioma discovered in a patient during peritoneal dialysis. The patient was a 55-year-old woman who had no history of asbestos exposure. Owing to end-stage kidney failure, she had been undergoing peritoneal dialysis for over 8 years, and she had been diagnosed with encapsulating peritoneal sclerosis. She was admitted to the hospital for intestinal obstruction. Three months later, she noticed an enlarging mass in the epigastric region. Computed tomography showed a 10-cm mass originating in the abdominal wall that had invaded the liver...
2016: Tokai Journal of Experimental and Clinical Medicine
https://www.readbyqxmd.com/read/27596540/surgical-management-of-complications-with-peritoneal-dialysis
#7
Andrzej Ratajczak, Małgorzata Lange-Ratajczak, Adam Bobkiewicz, Adam Studniarek
This report reviews the most common surgical interventions and complications of chronic peritoneal dialysis (PD) patients. Based on the current knowledge as well as our experience we detail the role of these surgical procedures. We supplement the reported knowledge in the field with our own experience in this area. The areas discussed include early complications such as surgical wound hemorrhage, bleeding from the catheter, intestinal perforation and urinary bladder perforation, dialysate leakage through the wound, as well as late complications including catheter kinking or occlusion, retention of fluid in the peritoneal recess, hernias and hydrothorax, and encapsulating peritoneal sclerosis...
September 6, 2016: Seminars in Dialysis
https://www.readbyqxmd.com/read/27556577/risk-factors-for-encapsulating-peritoneal-sclerosis-analysis-of-a-36-year-experience-in-a-university-hospital
#8
Masatsugu Nakao, Izumi Yamamoto, Yukio Maruyama, Masamitsu Morishita, Akio Nakashima, Nanae Matsuo, Yudo Tanno, Ichiro Ohkido, Masato Ikeda, Hiroyasu Yamamoto, Keitaro Yokoyama, Takashi Yokoo
AIM: Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication that occurs in peritoneal dialysis (PD) therapy. The present study aimed to identify the risk factors, especially peritonitis and biocompatible PD fluid. METHODS: The study included 703 patients who received PD between January 1980 and March 2015 at two centers. The patients were divided into two groups: those who had developed EPS (EPS group: n = 44) and those who had no documentary evidence of EPS (non-EPS group: n = 659)...
August 24, 2016: Nephrology
https://www.readbyqxmd.com/read/27540308/the-number-of-patients-with-severe-encapsulating-peritoneal-sclerosis-is-decreasing-in-a-large-referral-center-in-germany
#9
Daniel Kitterer, Niko Braun, M Dominik Alscher, Stephan Segerer, Joerg Latus
BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is the most severe complication associated with long-term peritoneal dialysis (PD). Previous studies noticed a sharp decline in new patients with severe EPS. We investigated the number of severe EPS patients in our large referral center over almost 20 years. METHODS: All late-stage EPS patients who underwent major surgery due to extensive symptoms caused by bowel obstruction (vomiting, abdominal pain, and weight loss) between March 1997 and end of December 2015 in our hospital were included in the present study...
2016: International Journal of Nephrology and Renovascular Disease
https://www.readbyqxmd.com/read/27478609/incidence-and-outcome-of-encapsulating-peritoneal-sclerosis
#10
Michaela C Petrie, Jamie P Traynor, Robert A Mactier
BACKGROUND: Studies report variation in the incidence and outcomes of encapsulating peritoneal sclerosis (EPS). This study reports the incidence and outcome of EPS cases in a national cohort of peritoneal dialysis (PD) patients. METHODS: The incident cohort of adult patients who started PD between 1 January 2000 and 31 December 2007 in Scotland (n = 1238) was identified from the Scottish Renal Registry. All renal units in Scotland identified potential EPS cases diagnosed from 1 January 2000 to 31 December 2014, by which point all patients had a minimum of 7 years follow-up from start of PD...
August 2016: Clinical Kidney Journal
https://www.readbyqxmd.com/read/27425661/mtor-inhibitors-for-management-of-encapsulating-peritoneal-sclerosis-a-review-of-literatures
#11
Maryam Ghadimi, Simin Dashti-Khavidaki, Hossein Khalili
BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is an infrequent, serious complication of peritoneal dialysis (PD). EPS may develop after kidney transplantation of PD-treated patients possibly due to the fibrotic effect of calcineurin inhibitors (CNIs). Some experimental and clinical studies proposed inhibitors of mammalian target of rapamycin (mTOR) for EPS management due to their anti-fibrotic and anti-angiogenesis effects. This review evaluated the therapeutic role of mTOR inhibitors in the management of EPS...
July 17, 2016: Renal Failure
https://www.readbyqxmd.com/read/27119341/vascular-endothelial-cell-injury-is-an-important-factor-in-the-development-of-encapsulating-peritoneal-sclerosis-in-long-term-peritoneal-dialysis-patients
#12
Mitsuhiro Tawada, Yasuhiko Ito, Chieko Hamada, Kazuho Honda, Masashi Mizuno, Yasuhiro Suzuki, Fumiko Sakata, Takeshi Terabayashi, Yoshihisa Matsukawa, Shoichi Maruyama, Enyu Imai, Seiichi Matsuo, Yoshifumi Takei
BACKGROUND AND OBJECTIVES: Encapsulating peritoneal sclerosis (EPS) is a rare but serious and life-threatening complication of peritoneal dialysis (PD). However, the precise pathogenesis remains unclear; in addition, predictors and early diagnostic biomarkers for EPS have not yet to be established. METHODS: Eighty-three peritoneal membrane samples taken at catheter removal were examined to identify pathological characteristics of chronic peritoneal deterioration, which promotes EPS in patients undergoing long-term PD treatment with low occurrence of peritonitis...
2016: PloS One
https://www.readbyqxmd.com/read/27067218/-a-case-of-encapsulating-of-peritoneal-sclerosis-with-fast-and-ominous-evolution
#13
Gioacchino Li Cavoli, Angelo Tralongo, Nazzarena Arena, Baldassare Scaturro, Filippo Carollo, Tancredi Vincenzo Li Cavoli, Pietro Tralongo, Ugo Rotolo
Encapsulating peritoneal sclerosis (EPS) is a rare and life-threatening complication of long-term peritoneal dialysis and until now, there is no established medical treatment for it. Many factors have been incriminated in its pathogenesis but they do not explain all risk conditions. EPS is significantly associated with PD duration, particularly more than 5 years, however the relationship between long-term PD and EPS increased risk is currently unknown. The "two-hit hypothesis" analyzes the relationship between the histological changes Peritoneal Dialysis-induced and intercurrent acute inflammatory episodes, but it does not explain the transition from Sclerosis Simple to EPS...
March 2016: Giornale Italiano di Nefrologia: Organo Ufficiale Della Società Italiana di Nefrologia
https://www.readbyqxmd.com/read/27006441/ultrafiltration-failure-and-impaired-sodium-sieving-during-long-term-peritoneal-dialysis-more-than-aquaporin-dysfunction
#14
Johann Morelle, Amadou Sow, Nicolas Hautem, Olivier Devuyst, Eric Goffin
Fifteen years ago, our group reported the case of a 67-year-old man on peritoneal dialysis for 11 years, in whom ultrafiltration failure and impaired sodium sieving were associated with an apparently normal expression of aquaporin-1 (AQP1) water channels in peritoneal capillaries. At that time, AQP1 dysfunction was suggested as the cause of impaired free-water transport. However, recent data from computer simulations, and structural and functional analysis of the peritoneal membrane of patients with encapsulating peritoneal sclerosis, demonstrated that changes in the peritoneal interstitium directly alter osmotic water transport...
March 2016: Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
https://www.readbyqxmd.com/read/26981446/matrix-metalloproteinase-2-as-a-superior-biomarker-for-peritoneal-deterioration-in-peritoneal-dialysis
#15
Ichiro Hirahara, Eiji Kusano, Yoshiyuki Morishita, Makoto Inoue, Tetsu Akimoto, Osamu Saito, Shigeaki Muto, Daisuke Nagata
AIM: To investigate the efficacy of effluent biomarkers for peritoneal deterioration with functional decline in peritoneal dialysis (PD). METHODS: From January 2005 to March 2013, the subjects included 218 PD patients with end-stage renal disease at 18 centers. Matrix metalloproteinase-2 (MMP-2), interleukin-6 (IL-6), hyaluronan, and cancer antigen 125 (CA125) in peritoneal effluent were quantified with enzyme-linked immunosorbent assay. Peritoneal solute transport rate was assessed by peritoneal equilibration test (PET) to estimate peritoneal deterioration...
March 6, 2016: World Journal of Nephrology
https://www.readbyqxmd.com/read/26908833/peritoneal-inflammation-precedes-encapsulating-peritoneal-sclerosis-results-from-the-global-fluid-study
#16
MULTICENTER STUDY
Mark R Lambie, James Chess, Angela M Summers, Paul Ford Williams, Nicholas Topley, Simon J Davies
BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is an uncommon condition, strongly associated with a long duration of peritoneal dialysis (PD), which is itself associated with increased fibrosis in the peritoneal membrane. The peritoneal membrane is inflamed during PD and inflammation is often associated with fibrosis. We hypothesized that patients who subsequently develop EPS might have a more inflamed peritoneal membrane during PD. METHODS: We performed a nested, case-control study identifying all EPS cases in the UK arm of the GLOBAL Fluid Study and matching them by centre and duration of PD with two to three controls...
March 2016: Nephrology, Dialysis, Transplantation
https://www.readbyqxmd.com/read/26831022/long-term-success-with-adhesiolysis-in-post-transplant-encapsulating-peritoneal-sclerosis-a-retrospective-case-series-of-4-patients-and-review-of-the-literature
#17
REVIEW
Ebru Gok Oguz, Gulay Ulusal Okyay, Ozgur Merhametsiz, Sadik Ersoz, Basol Canbakan, Deniz Ayli
Encapsulating peritoneal sclerosis (EPS) is an occasional and serious complication for peritoneal dialysis (PD) patients for whom no evidence-based management strategies have yet been established. Encapsulating peritoneal sclerosis could appear after kidney transplantation in patients who previously underwent long-term PD. In this report, we present our experience in four PD patients diagnosed with EPS after kidney transplantation. Adhesiolysis provided improvement in their acute clinical conditions and allograft functions, despite the long-term follow-up...
2016: Internal Medicine
https://www.readbyqxmd.com/read/26730546/can-radiological-assessment-of-abdominal-computerized-scans-diagnose-encapsulating-peritoneal-sclerosis-in-long-term-peritoneal-dialysis-patients
#18
Sam Stuart, David Stott, Antony Goode, Charlotte J Cash, Andrew Davenport
INTRODUCTION: Encapsulating peritoneal sclerosis (EPS) is a rare but potentially devastating complication of long term peritoneal dialysis (PD). Changes to the peritoneal membrane occur with duration of PD therapy. To determine the potential effect of prospective CT scanning we reviewed the scans of patients who had developed EPS compared to those without EPS. METHODS: We retrospectively compared CT scans which had been prospectively performed in a screening program for PD patients after 4 years of PD and compared scans from 18 patients with confirmed EPS and 26 vintage matched controls without EPS...
January 5, 2016: Nephrology
https://www.readbyqxmd.com/read/26718649/the-therapeutic-potential-of-human-umbilical-mesenchymal-stem-cells-from-wharton-s-jelly-in-the-treatment-of-rat-peritoneal-dialysis-induced-fibrosis
#19
Yu-Pei Fan, Ching-Chih Hsia, Kuang-Wen Tseng, Chih-Kai Liao, Tz-Win Fu, Tsui-Ling Ko, Mei-Miao Chiu, Yang-Hsin Shih, Pei-Yu Huang, Yi-Chia Chiang, Chih-Ching Yang, Yu-Show Fu
A major complication in continuous, ambulatory peritoneal dialysis in patients with end-stage renal disease who are undergoing long-term peritoneal dialysis (PD) is peritoneal fibrosis, which can result in peritoneal structural changes and functional ultrafiltration failure. Human umbilical mesenchymal stem cells (HUMSCs) in Wharton's jelly possess stem cell properties and are easily obtained and processed. This study focuses on the effects of HUMSCs on peritoneal fibrosis in in vitro and in vivo experiments...
February 2016: Stem Cells Translational Medicine
https://www.readbyqxmd.com/read/26561223/encapsulating-peritoneal-sclerosis-surgery-sustained-drug-therapy-and-treatment-of-recurrence-at-1-year
#20
Robin Cho, Danielle Ghag, Mohamud Amirali Karim, Clifford Lo
A 74-year-old woman with end-stage renal disease presented with clinical symptoms of encapsulating peritoneal sclerosis 2 years after switching from peritoneal dialysis to haemodialysis. Imaging revealed a large cystic structure in her abdomen and her final diagnosis was made by exploratory laparotomy. A 10 cm×15 cm fibrous rind was excised from the peritoneum and the patient was subsequently started on tamoxifen 20 mg daily and prednisone 20 mg daily. Given her reduction in clinical symptoms and concerns about the long-term effects of corticosteroids, prednisone was tapered and she remained on tamoxifen monotherapy...
2015: BMJ Case Reports
keyword
keyword
10010
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"